Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Licenses IntegraGen's Autism IP

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic said today that it has licensed intellectual property from IntegraGen that it plans to use to develop a genetic test for autism risk in children who have older siblings who have already been diagnosed with an autism spectrum disorder.

Omaha, Neb.-based Transgenomic said that it will develop the test internally and expects it to be ready for launch by its CLIA-certified lab in the second quarter of 2010.

"We believe that the use of this test in conjunction with standard diagnostic tools will allow for the earlier diagnosis of autism, and importantly, the more timely initiation of treatment plans for these children," Transgenomic CEO and President Craig Tuttle said in a statement.

In addition to discovering genes and genetic variations for use in molecular diagnostic tests, Evry, France-based IntegraGen offers genotyping services to the research community.

Financial terms of the agreement were not released.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.